Recent studies reveal lymphoma accelerates aging in immune cells and tissues, illuminating cancer's broader systemic effects. Additionally, new findings identify regulatory T cells expressing a FOXP3 variant that can reprogram tumor immunosuppression, proposing innovative targets to enhance antitumor immunity.